ID   ESi070-A
AC   CVCL_WP79
SY   [DUPSW]FiPS 501-R4F-2; DUPSW FiPS 501-R4F-2; DUPSW FiPS501 R4F-2
DR   BioSamples; SAMEA5843914
DR   hPSCreg; ESi070-A
DR   Wikidata; Q93545391
RX   PubMed=33254092;
WW   https://p-cmrc.cat/wp-content/uploads/2020/06/DUPSW-FiPS-501-RAF-2.pdf
WW   https://www.isciii.es/QueHacemos/Servicios/BIOBANCOS/BNLC/Lists/Lneas%20iPS/Attachments/148/Caracteristicas%20-%20DUPSW%20FiPS%20501-R4F-2-V2.pdf
WW   https://www.isciii.es/QueHacemos/Servicios/BIOBANCOS/BNLC/Lists/Lneas%20iPS/Attachments/148/Anexo%20-%20Anexo_dep%c3%b3sito_DUPSW%20FiPS%20501-R4F-2-V2.pdf
CC   Part of: Spanish Stem Cell Bank (Banco Nacional de Lineas Celulares) collection.
CC   From: Centro de Medecina Regenerativa de Barcelona (CMRB); Barcelona; Spain.
CC   Derived from site: In situ; Skin, dermis; UBERON=UBERON_0002067.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): BNLC
ST   Amelogenin: X,Y
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D21S11: 27,28
ST   D5S818: 12,13
ST   D7S820: 9,11
ST   TH01: 8,9.3
ST   TPOX: 8,11
ST   vWA: 16,18
DI   NCIt; C88412; Autism spectrum disorder
DI   NCIt; C165597; Williams-Beuren region duplication syndrome
DI   ORDO; Orphanet_96121; 7q11.23 microduplication syndrome
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   17Y
CA   Induced pluripotent stem cell
DT   Created: 05-07-19; Last updated: 30-01-24; Version: 10
//
RX   PubMed=33254092; DOI=10.1016/j.scr.2020.102092;
RA   Kuebler B., Aran B., Flores R., Perez-Jurado L.A., Veiga A., Cusco I.,
RA   Corominas R.;
RT   "Derivation of induced pluripotent stem cells (iPSCs) by retroviral
RT   transduction of skin fibroblasts from four patients suffering 7q11.23
RT   microduplication syndrome.";
RL   Stem Cell Res. 49:102092-102092(2020).
//